Amgen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

28.09.17	Amgen, AbbVie Settle Litigation Regarding AMGEVITA - Quick Facts (RTTNews)
26.09.17	Amgen And Simcere Announce Strategic Collaboration To Co-Develop And Commercialize Biosimilars In China (PR Newswire)
25.09.17	Amgen Updates On Hurricane Maria (RTTNews)
25.09.17	Amgen Provides Update On Hurricane Maria (PR Newswire)
22.09.17	Amgen Foundation Pledges Up To $5 Million To Hurricane Maria Relief Efforts (PR Newswire)
21.09.17	AMGEN (AMGN) ALERT: Johnson Fistel Announces Investigation of Amgen Inc.; Investors that Bought Before March 17, 2017, Encouraged to Contact the Firm (PR Newswire)
15.09.17	Republic Services, Inc. Sets Date for Third Quarter 2017 Earnings Release and Conference Call (PR Newswire)
15.09.17	New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes (PR Newswire)
14.09.17	FDA Approves Amgen And Allergan's MVASI™ (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer (PR Newswire)
14.09.17	Roche-Medikament Avastin: FDA bewilligt Nachahmerprodukt von Amgen (AWP) Das Roche-Krebsmedikament Avastin erhält in den USA Konkurrenz durch ein Nachahmerprodukt.» mehr
14.09.17	Roche-Medikament Avastin: FDA bewilligt Nachahmerprodukt von Amgen (AWP)
14.09.17	Biotech Sector Looking to Outperform in 2017 (PR Newswire)
11.09.17	Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference (PR Newswire)
11.09.17	EVENITY™ (romosozumab) ARCH Study Results Published In The New England Journal Of Medicine (PR Newswire)
09.09.17	Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress (PR Newswire)
08.09.17	Christmas Comes Early For KURA, ANTH On Track, ABBV Hits All-time High (RTTNews)
07.09.17	New Data Demonstrate Aimovig™ (erenumab) Reduced Monthly Migraine Days In Patients Who Failed Previous Preventive Therapies (PR Newswire)
07.09.17	Amgen To Present At The Morgan Stanley Global Healthcare Conference (PR Newswire)
07.09.17	CH2M named to Fortune's Top 50 Companies that Change the World (PR Newswire)
07.09.17	AstraZeneca Announces Results From PATHWAY Phase IIb Trial Of Tezepelumab (RTTNews)
06.09.17	Tezepelumab Significantly Reduced Asthma Exacerbations For A Broad Population Of Patients With Severe Uncontrolled Asthma (PR Newswire)
05.09.17	Decline in Pharmacy Customer Satisfaction Driven by Prescription Drug Costs, J.D. Power Finds (PR Newswire)
04.09.17	UBS Keyinvest Daily Markets: Amgen - Setzt sich die Rally fort? (finanzen.ch)
31.08.17	European Commission Approves Expanded Use Of Mimpara® (Cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Children With End-Stage Renal Disease On Dialysis (PR Newswire)
31.08.17	Digital Realty to Present at Investor Conferences in September 2017 (PR Newswire)
31.08.17	AMGN's Endeavor Awaits Verdict, NVS Scripts History, OTIC Is Not Music To Ears (RTTNews)
30.08.17	Long-Term Analysis Of Phase 3 Head-To-Head Study Confirms KYPROLIS® (Carfilzomib) Regimen Extends Overall Survival In Patients With Relapsed Multiple Myeloma (PR Newswire)
30.08.17	FDA Accepts Amgen's Filing Of A Supplemental New Drug Application To Add Overall Survival Results To KYPROLIS® (Carfilzomib) Label (PR Newswire)
29.08.17	New Virtual Histology Sub-Study Evaluates Impact Of Repatha® (Evolocumab) On Coronary Artery Plaque Composition (PR Newswire)
29.08.17	New Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With History Of Stroke (PR Newswire)
29.08.17	Biotech Stocks Facing FDA Decision In September (RTTNews)
28.08.17	Amgen Reports New Repatha Analysis - Quick Facts (RTTNews)
28.08.17	New Repatha® (evolocumab) Analysis Demonstrates Cardiovascular Outcomes Efficacy And Safety Of Achieving Very Low LDL-C Levels (PR Newswire)
24.08.17	Amgen Foundation Expands The Amgen Biotech Experience, Bringing Total Program Reach To 900,000 High School Students By 2020 (PR Newswire)
24.08.17	Overall Survival Analysis From KYPROLIS® (carfilzomib) Phase 3 Endeavor Trial Published In The Lancet Oncology (PR Newswire)
23.08.17	New Economic Analysis Based On Repatha® (Evolocumab) Outcomes Data Published In JAMA Cardiology (PR Newswire)
21.08.17	Amgen To Present New Data From The Repatha® (Evolocumab) Cardiovascular Outcomes Study At ESC Congress 2017 (PR Newswire)
18.08.17	FDA Nod For PFE, New Use For AZN's Ovarian Cancer Drug, ELGX's LEOPARD Hits Goal (RTTNews)
16.08.17	Repatha® (Evolocumab) Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine (PR Newswire)
08.08.17	Scottish Medicines Consortium Accepts Amgen's Multiple Myeloma Treatment, KYPROLIS® ▼ (carfilzomib), in Combination with Dexamethasone, for use at First Relapse (PR Newswire)
31.07.17	Amgen Submits Supplemental Biologics License Application For Prolia® (denosumab) In Glucocorticoid-Induced Osteoporosis (PR Newswire)
31.07.17	Amgen And Allergan Submit Biosimilar BLA For ABP 980 To FDA (RTTNews)
31.07.17	Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 980 To US Food And Drug Administration (PR Newswire)
28.07.17	Amgen Announces 2017 Third Quarter Dividend (PR Newswire)
28.07.17	AGRX At FDA Altar Again, AZN Falls As MYSTIC Fails, VBIV Delivers A Good Shot (RTTNews)
27.07.17	FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha® (evolocumab) To Include Data On Reducing Risk Of Cardiovascular Events (PR Newswire)
26.07.17	MÄRKTE USA/Rekordjagd - Boeing im Höhenflug - Dollar unter Druck (Dow Jones)
26.07.17	Amgen schneidet besser ab als erwartet und erhöht Prognose (AWP) Der weltweit grösste Biotech-Konzern Amgen hat es nicht leicht mit der Börse.» mehr
25.07.17	Amgen Inc. Reports 12% Gain In Q2 Bottom Line (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

17:58		Handel in Frankfurt: SDAX liegt letztendlich im Plus
17:58		Schwache Performance in Europa: Euro STOXX 50 gibt letztendlich nach
15:58		Schwache Performance in Frankfurt: TecDAX zeigt sich nachmittags schwächer
15:58		Handel in Europa: So bewegt sich der Euro STOXX 50 aktuell
15:58		XETRA-Handel: SDAX am Nachmittag freundlich
13:28		Bayer-Analyse: DZ BANK verleiht Bayer-Aktie Kaufen in jüngster Analyse
12:26		Schwacher Wochentag in Europa: So performt der Euro STOXX 50 mittags
12:26		Mittwochshandel in Frankfurt: TecDAX gibt am Mittag nach

17:58

Handel in Frankfurt: SDAX liegt letztendlich im Plus

17:58

Schwache Performance in Europa: Euro STOXX 50 gibt letztendlich nach

15:58

Schwache Performance in Frankfurt: TecDAX zeigt sich nachmittags schwächer

15:58

Handel in Europa: So bewegt sich der Euro STOXX 50 aktuell

15:58

XETRA-Handel: SDAX am Nachmittag freundlich

13:28

Bayer-Analyse: DZ BANK verleiht Bayer-Aktie Kaufen in jüngster Analyse